A. Lledó

780 total citations
15 papers, 538 citations indexed

About

A. Lledó is a scholar working on Neurology, Infectious Diseases and Surgery. According to data from OpenAlex, A. Lledó has authored 15 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 4 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in A. Lledó's work include COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). A. Lledó is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (3 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). A. Lledó collaborates with scholars based in Spain, United Kingdom and United States. A. Lledó's co-authors include Francisco Molina‐Holgado, Carmen Guaza, Miriam Retuerto, José L. Pablos, María Galindo-Izquierdo, Natalia Mena‐Vázquez, Ricardo Blanco, Loreto Carmona, David Fernandez-Fernández and M.J. Brodie and has published in prestigious journals such as Neurology, Annals of the Rheumatic Diseases and Neuroreport.

In The Last Decade

A. Lledó

15 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Lledó Spain	9	200	124	123	101	99	15	538
Thomas J. Geller United States	14	131 0.7×	31 0.3×	40 0.3×	95 0.9×	82 0.8×	30	574
Maria Rosaria Tola Italy	16	327 1.6×	21 0.2×	87 0.7×	35 0.3×	67 0.7×	23	633
Alessandra Morano Italy	16	108 0.5×	44 0.4×	234 1.9×	92 0.9×	91 0.9×	70	784
Yaron River Israel	11	178 0.9×	15 0.1×	55 0.4×	53 0.5×	46 0.5×	26	591
Carlos Eduardo Silvado Brazil	16	68 0.3×	49 0.4×	81 0.7×	24 0.2×	55 0.6×	52	587
David A. Kaku United States	9	355 1.8×	63 0.5×	493 4.0×	29 0.3×	21 0.2×	10	919
Dawn McGuire United States	8	169 0.8×	98 0.8×	240 2.0×	34 0.3×	10 0.1×	9	769
Chusak Limotai Thailand	11	69 0.3×	30 0.2×	48 0.4×	313 3.1×	75 0.8×	31	604
Rosa Ana Sáiz Díaz Spain	13	112 0.6×	26 0.2×	150 1.2×	18 0.2×	59 0.6×	36	578
Omidvar Rezaei Iran	14	161 0.8×	26 0.2×	115 0.9×	28 0.3×	17 0.2×	68	627

Countries citing papers authored by A. Lledó

Since Specialization

Citations

This map shows the geographic impact of A. Lledó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lledó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lledó more than expected).

Fields of papers citing papers by A. Lledó

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lledó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lledó. The network helps show where A. Lledó may publish in the future.

Co-authorship network of co-authors of A. Lledó

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lledó. A scholar is included among the top collaborators of A. Lledó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lledó. A. Lledó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Retuerto, Miriam, A. Lledó, Rosa Guerrero, et al.. (2022). Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities. Immunity & Ageing. 19(1). 38–38. 14 indexed citations

Lledó, A., Miriam Retuerto, Patricia Almendro-Vázquez, et al.. (2021). SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy. Seminars in Arthritis and Rheumatism. 51(6). 1258–1262. 5 indexed citations

Pablos, José L., María Galindo-Izquierdo, Loreto Carmona, et al.. (2020). Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Annals of the Rheumatic Diseases. 79(12). 1544–1549. 137 indexed citations

Pablos, José L., María Galindo-Izquierdo, Loreto Carmona, et al.. (2020). Clinical Outcomes of Patients with COVID-19 and Chronic Inflammatory and Autoimmune Rheumatic Diseases: A Multicentric Matched-Cohort Study. SSRN Electronic Journal. 1 indexed citations

Marchettini, Paolo, Stefan Wilhelm, Helmut Petto, et al.. (2015). Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?. European Journal of Pain. 20(3). 472–482. 28 indexed citations

Lledó, A., et al.. (2007). Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists. European Journal of Neurology. 14(6). 644–649. 8 indexed citations

Trenkwalder, C., Hans‐Peter Hundemer, A. Lledó, et al.. (2004). Efficacy of pergolide in treatment of restless legs syndrome. Neurology. 62(8). 1391–1397. 82 indexed citations

Chappell, Amy S., Josemir W. Sander, M.J. Brodie, et al.. (2002). A crossover, add-on trial of talampanel in patients with refractory partial seizures. Neurology. 58(11). 1680–1682. 79 indexed citations

Lledó, A.. (2000). Dopamine agonists: the treatment for Parkinson's disease in the XXI century?. Parkinsonism & Related Disorders. 7(1). 51–58. 22 indexed citations

10.

Molina‐Holgado, Francisco, A. Lledó, & Carmen Guaza. (1997). Anandamide suppresses nitric oxide and TNF-α responses to Theilerʼs virus or endotoxin in astrocytes. Neuroreport. 8(8). 1929–1933. 91 indexed citations

11.

Andrés, Clara de & A. Lledó. (1997). [Fatty diet and multiple sclerosis].. PubMed. 25(148). 2032–5. 4 indexed citations

12.

Jensen, Mark A., et al.. (1996). Reply from the Authors. Neurology. 47(3). 854–855. 1 indexed citations

13.

Lledó, A., et al.. (1994). Acute Headache of Recent Onset and Subarachnoid Hemorrhage: A Prospective Study. Headache The Journal of Head and Face Pain. 34(3). 172–174. 25 indexed citations

14.

Lledó, A., et al.. (1992). [Neuroleptic malignant syndrome associated with the inadequate antidiuretic hormone secretion syndrome].. PubMed. 55(2). 75–8. 3 indexed citations

15.

Boixeda, D, et al.. (1983). Treatment of liver hydatid disease with mebendazole: a prospective study of thirteen cases.. PubMed. 78(9). 584–8. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact